Commerce Bank purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 19,333 shares of the medical research company's stock, valued at approximately $2,568,000.
Several other large investors have also recently added to or reduced their stakes in A. SHP Wealth Management acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $26,000. Core Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $26,000. Navalign LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $27,000. MV Capital Management Inc. purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at about $28,000. Finally, Entrust Financial LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at about $31,000.
Wall Street Analyst Weigh In
Several equities analysts recently commented on A shares. Sanford C. Bernstein started coverage on Agilent Technologies in a research report on Friday, June 26th. They set an "outperform" rating and a $155.00 price target on the stock. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Sunday, August 2nd. Barclays boosted their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 24th. HSBC decreased their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Wednesday, June 3rd. Finally, Wolfe Research reaffirmed a "hold" rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $160.24.
Get Our Latest Report on Agilent Technologies
Agilent Technologies Trading Down 3.5%
Shares of A opened at $153.37 on Tuesday. The company has a market capitalization of $43.32 billion, a P/E ratio of 30.80, a P/E/G ratio of 2.80 and a beta of 1.25. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.51. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a 50-day moving average price of $138.03 and a 200 day moving average price of $126.32.
Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the business earned $1.31 EPS. Agilent Technologies's revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6.05 EPS for the current fiscal year.
Agilent Technologies Profile
(
Free Report)
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Recommended Stories
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.